Core Viewpoint - Lionhead Co., Ltd. has announced a significant change in its acquisition plan for Lipu Technology, reducing the acquisition stake from 100% to 97.4399% due to unpaid transfer payments by the founder [2][7]. The financial performance of Lipu Technology has deteriorated, with a projected net profit for 2024 revised down from 43.27 million to 35.01 million, indicating a nearly 20% reduction [2][12]. Financial Performance - Lipu Technology's asset-liability ratios as of the end of 2023, 2024, and May 2024 were 83.8%, 74.92%, and 71.21% respectively [3]. The company reported a revenue of 123 million in the first five months of this year, with inventory reaching 220 million [3]. The projected net profit for 2024 is 35.01 million, but the performance in the first five months has only yielded 295.5 thousand, less than 10% of the promised performance [3][12]. Acquisition Details - The acquisition involves issuing shares and cash to purchase 97.4399% of Lipu Technology from 14 parties, with a total valuation of 679.81 million [7][14]. The acquisition price reflects a price-to-earnings ratio of approximately 19.42 times based on the revised net profit for 2024 [2][14]. The issuance of new shares will account for 22.33% of the total post-issue share capital, priced at 6.69 per share, which is about 47% of the closing price on August 6 [8][17]. Strategic Intent - Lionhead Co., Ltd. aims to transform its business strategy by entering the machine vision sector through this acquisition, seeking to create a second growth curve and enhance its profitability [10]. However, the financial health of Lipu Technology raises concerns, with high levels of debt and inventory, and declining gross margins [11][12]. Valuation Concerns - The acquisition price represents a premium of nearly 300%, with a price-to-earnings ratio close to 20 times the projected net profit for 2024 [14]. The differentiated pricing strategy for various stakeholders in the acquisition indicates a complex valuation approach [14].

Core Viewpoint - Lionhead Co., Ltd. has announced a significant change in its acquisition plan for Lipu Technology, reducing the acquisition stake from 100% to 97.4399% due to unpaid share transfer payments by the founder [2][8]. The financial performance of Lipu Technology has also shown a notable decline, with the projected net profit for 2024 revised down from 43.27 million to 35.01 million, indicating a nearly 20% reduction [2][12]. Financial Performance - As of the end of 2023, Lipu Technology's asset-liability ratios were 83.8%, 74.92%, and 71.21% for the years 2023, 2024, and May 2025 respectively [3]. The company's revenue for the first five months of this year was 123 million, while its inventory reached 220 million, indicating a high inventory turnover issue [3][12]. - The net profit for Lipu Technology is projected at 35.01 million for 2024, with a performance commitment for 2025 set at "not less than 33 million," suggesting potential negative growth [12][13]. Acquisition Details - The acquisition involves purchasing 97.4399% of Lipu Technology's shares from 14 parties, with a total valuation of 679.8 million yuan, resulting in a price-to-earnings ratio of 19.42 [2][8]. The share issuance price for the new shares is set at 6.69 yuan, which is approximately 47% lower than the closing price on August 6 [8][12]. - The acquisition is structured with differentiated pricing for various transaction parties, with valuations ranging significantly, indicating a complex pricing strategy [18]. Strategic Intent - Lionhead Co., Ltd. aims to transform its business model by entering the machine vision sector through this acquisition, seeking to create a second growth curve and enhance its profitability [11][12]. However, the financial health of Lipu Technology raises concerns about the sustainability of this strategy given its high debt and inventory levels [10][12].

Core Viewpoint - The transaction involves the acquisition of 97.4399% of shares in Lipo Technology by Lionhead Technology through a combination of issuing shares and cash payment, with the independent financial advisor confirming the compliance with regulatory guidelines [1][2]. Industry and Company Summary - The main business of Lipo Technology focuses on the research, development, production, and sales of machine vision-related technology products, classified under "C35 Specialized Equipment Manufacturing" in the national economic industry classification [1]. - The independent financial advisor concluded that the industry involved in this transaction does not fall under the categories specified by the China Securities Regulatory Commission (CSRC) for urgent integration and transformation [2]. - The transaction type does not represent a merger within the same industry or upstream/downstream acquisition, as Lionhead Technology primarily operates in e-commerce services, while Lipo Technology serves various emerging manufacturing sectors [2][3]. - The transaction does not constitute a restructuring listing as there has been no change in the controlling shareholder or actual controller within the last thirty-six months [2][3]. - The transaction involves the issuance of shares as part of the acquisition process [3]. - As of the date of the independent financial advisor's opinion, Lionhead Technology is not under investigation by the CSRC [4].